A sodium-channel mutation causes isolated cardiac conduction disease

Area of Science:

• Genetics
• Cardiology
• Molecular Biology

Background:

• Cardiac conduction disorders affect millions globally, often linked to SCN5A gene mutations.
• While some SCN5A mutations cause rapid arrhythmias, others may affect normal heart rhythm.
• The precise mechanisms of SCN5A mutations causing conduction defects remain under investigation.

Purpose of the Study:

• To functionally characterize a novel SCN5A mutation causing isolated cardiac conduction defects.
• To investigate the molecular and biophysical properties of the identified mutation.
• To explore potential therapeutic interventions for the observed phenotype.

Main Methods:

• Genetic analysis of the SCN5A coding region in affected family members.
• Biophysical characterization of the mutant cardiac sodium channel (G514C).
• Computational analysis to predict the functional impact of the mutation.

Main Results:

• A single mutation (G514C) was identified in five family members, causing a sustained conduction defect.
• The G514C mutation alters voltage-dependent gating of the sodium channel.
• Dexamethasone partially corrected the gating abnormalities, aligning with clinical observations.

Conclusions:

• The G514C mutation in SCN5A leads to pathological slowing of cardiac rhythm, distinct from previously studied rapid arrhythmias.
• Understanding the specific gating defects of G514C provides crucial insights into cardiac impulse conduction.
• The partial correction by dexamethasone suggests a potential therapeutic avenue for related conduction disorders.